Eli Lilly’s revenue has soared in recent years thanks to its leadership in the weight loss drug market. Eli Lilly (NYSE: LLY) ...

Eli Lilly (NYSE:LLY) announced a significant global licensing and research collaboration with Juvena Therapeutics to explore ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

Eli Lilly and Company thrives on its groundbreaking weight-loss drug tirzepatide. Learn why we could see a $50B market and ...

Eli Lilly and Company (NYSE:LLY), a global pharmaceutical giant with a market capitalization of $648.31 billion, has been making waves in the healthcare sector with its innovative treatments and ...

We recently published a list of Did Jim Cramer Nail or Miss These 11 Stock Predictions? In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other ...

What caused Eli Lilly's stock to fall this week? During an earnings report, management will generally provide investors with a forecast for the next quarter and potentially the full year.

Aleniglipron’s tolerability could be a differentiator for Structure Therapeutics, but its efficacy lags competitors. Read why ...

The U.S.-listed shares of Danish drugmaker Novo Nordisk rose Tuesday following a report that an activist investor is building ...

During the most recent episode of Mad Money, Jim Cramer opened the show by emphasizing just how much American companies ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.